PDGFRB and Hepatic fibrosis: The sensitivity, specificity, PPV, and NPV of PDGFRβ to predict significant liver fibrosis in diabetic MAFLD patients were 85%, 93.33%, 89.5%, and 90.3%, respectively, at a cutoff > 2.54.